【摘要】 短链脂肪酸(SCFAs)在肠道微生物群调控宿主代谢中起到了主要介导作用，且与2型糖尿病(T2DM)密切相关，可改善T2DM患者的血糖、体质量和血脂指标。尽管有学者认为SCFAs有望成为T2DM的新型治疗靶点，但目前尚未有相关综述。本文总结了短链脂肪酸的生物学特性，讨论了SCFAs调节食欲、炎症、胰岛β细胞、脂质代谢与肝脏糖原代谢的证据，进一步明确调控SCFAs在T2DM中的作用及其研究进展，探讨了调控SCFAs治疗T2DM的潜力。

    【关键词】 糖尿病，2型；短链脂肪酸；胃肠道微生物组；代谢；研究进展

    【中图分类号】 R 587.1 【文献标识码】 A DOI：10.12114/j.issn.1007-9572.2023.0533

    Advances in the Role of Short-chain Fatty Acids in Type 2 Diabetes

    JIANG Rongsheng，ZHANG Long，GUAN Qifan，ZHANG Jing，WU Yuanfeng，LIU Mingjun*

    School of Acupuncture and Tuina，Changchun University of Chinese Medicine，Changchun 130117，China

    *Corresponding author：LIU Mingjun，Professor；E-mail：195433711@qq.com

    【Abstract】 Short-chain fatty acids(SCFAs)play a major mediating role in gut microbiota regulation of host metabolism and are strongly associated with type 2 diabetes mellitus (T2DM)，which improves glycemic，body weight，and lipid indices in T2DM patients. Although it has been suggested that SCFAs are expected to be novel therapeutic targets for T2DM，no review has been conducted. Therefore，this paper summarizes the biological properties of SCFAs ......